Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Buy
57
OILFF Quote, Financials, Valuation and Earnings
Last price:
$0.04
Seasonality move
:
-11.66%
Day range:
$0.04 - $0.05
52-week range:
$0.03 - $0.07
Dividend yield:
0%
P/E ratio:
15.35x
P/S ratio:
0.76x
P/B ratio:
1.64x
Volume:
76.3K
Avg. volume:
59.2K
1-year change:
-19.07%
Market cap:
$6.7M
Revenue:
$9.2M
EPS (TTM):
-$0.01
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
OILFF
Nextleaf Solutions Ltd.
|
-- | -- | -- | -- | -- |
|
AUPH
Aurinia Pharmaceuticals, Inc.
|
$67.7M | $0.16 | 25.05% | 2133.71% | $16.67 |
|
EDSA
Edesa Biotech, Inc.
|
-- | -- | -- | -- | $11.00 |
|
LEXX
Lexaria Bioscience Corp.
|
$50K | -- | 63.1% | -- | $6.00 |
|
ONCY
Oncolytics Biotech, Inc.
|
-- | -$0.05 | -- | -15.25% | $5.55 |
|
XENE
Xenon Pharmaceuticals, Inc.
|
-- | -$1.16 | -- | -43.57% | $55.40 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
OILFF
Nextleaf Solutions Ltd.
|
$0.04 | -- | $6.7M | 15.35x | $0.00 | 0% | 0.76x |
|
AUPH
Aurinia Pharmaceuticals, Inc.
|
$16.18 | $16.67 | $2.1B | 28.84x | $0.00 | 0% | 8.59x |
|
EDSA
Edesa Biotech, Inc.
|
$1.48 | $11.00 | $10.4M | -- | $0.00 | 0% | 31.22x |
|
LEXX
Lexaria Bioscience Corp.
|
$0.58 | $6.00 | $14.5M | -- | $0.00 | 0% | 14.86x |
|
ONCY
Oncolytics Biotech, Inc.
|
$1.01 | $5.55 | $108.7M | -- | $0.00 | 0% | -- |
|
XENE
Xenon Pharmaceuticals, Inc.
|
$44.10 | $55.40 | $3.4B | -- | $0.00 | 0% | 463.46x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
OILFF
Nextleaf Solutions Ltd.
|
7.86% | 1.671 | 3.9% | 0.16x |
|
AUPH
Aurinia Pharmaceuticals, Inc.
|
17.62% | -0.123 | 5.37% | 5.02x |
|
EDSA
Edesa Biotech, Inc.
|
-- | -0.273 | -- | 10.60x |
|
LEXX
Lexaria Bioscience Corp.
|
2.06% | -1.067 | 0.6% | 3.11x |
|
ONCY
Oncolytics Biotech, Inc.
|
87.89% | 4.153 | 0.41% | 1.61x |
|
XENE
Xenon Pharmaceuticals, Inc.
|
1.47% | 0.195 | 0.27% | 12.08x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
OILFF
Nextleaf Solutions Ltd.
|
$420.5K | -$16.4K | 11.09% | 11.96% | -0.78% | -$270.3K |
|
AUPH
Aurinia Pharmaceuticals, Inc.
|
$65.3M | $30.7M | 17.52% | 21.42% | 41.75% | $44.9M |
|
EDSA
Edesa Biotech, Inc.
|
-$25.9K | -$2.5M | -77.45% | -77.48% | -- | -$1.8M |
|
LEXX
Lexaria Bioscience Corp.
|
$152.6K | -$2.5M | -144.76% | -147.19% | -2155.4% | -$3.6M |
|
ONCY
Oncolytics Biotech, Inc.
|
-$67.5K | -$10M | -540.79% | -635.07% | -- | -$4.9M |
|
XENE
Xenon Pharmaceuticals, Inc.
|
-$641K | -$96.3M | -43.83% | -44.39% | -969.84% | -$72.7M |
Nextleaf Solutions Ltd. vs. Competitors
-
Which has Higher Returns OILFF or AUPH?
Aurinia Pharmaceuticals, Inc. has a net margin of -0.41% compared to Nextleaf Solutions Ltd.'s net margin of 42.95%. Nextleaf Solutions Ltd.'s return on equity of 11.96% beat Aurinia Pharmaceuticals, Inc.'s return on equity of 21.42%.
Company Gross Margin Earnings Per Share Invested Capital OILFFNextleaf Solutions Ltd.19.98% -- $4.5M AUPHAurinia Pharmaceuticals, Inc.88.87% $0.23 $444M -
What do Analysts Say About OILFF or AUPH?
Nextleaf Solutions Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Aurinia Pharmaceuticals, Inc. has an analysts' consensus of $16.67 which suggests that it could grow by 3.01%. Given that Aurinia Pharmaceuticals, Inc. has higher upside potential than Nextleaf Solutions Ltd., analysts believe Aurinia Pharmaceuticals, Inc. is more attractive than Nextleaf Solutions Ltd..
Company Buy Ratings Hold Ratings Sell Ratings OILFFNextleaf Solutions Ltd.0 0 0 AUPHAurinia Pharmaceuticals, Inc.4 3 0 -
Is OILFF or AUPH More Risky?
Nextleaf Solutions Ltd. has a beta of 1.769, which suggesting that the stock is 76.904% more volatile than S&P 500. In comparison Aurinia Pharmaceuticals, Inc. has a beta of 1.425, suggesting its more volatile than the S&P 500 by 42.546%.
-
Which is a Better Dividend Stock OILFF or AUPH?
Nextleaf Solutions Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Aurinia Pharmaceuticals, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nextleaf Solutions Ltd. pays -- of its earnings as a dividend. Aurinia Pharmaceuticals, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OILFF or AUPH?
Nextleaf Solutions Ltd. quarterly revenues are $2.1M, which are smaller than Aurinia Pharmaceuticals, Inc. quarterly revenues of $73.5M. Nextleaf Solutions Ltd.'s net income of -$8.6K is lower than Aurinia Pharmaceuticals, Inc.'s net income of $31.6M. Notably, Nextleaf Solutions Ltd.'s price-to-earnings ratio is 15.35x while Aurinia Pharmaceuticals, Inc.'s PE ratio is 28.84x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nextleaf Solutions Ltd. is 0.76x versus 8.59x for Aurinia Pharmaceuticals, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OILFFNextleaf Solutions Ltd.0.76x 15.35x $2.1M -$8.6K AUPHAurinia Pharmaceuticals, Inc.8.59x 28.84x $73.5M $31.6M
-
Which has Higher Returns OILFF or EDSA?
Edesa Biotech, Inc. has a net margin of -0.41% compared to Nextleaf Solutions Ltd.'s net margin of --. Nextleaf Solutions Ltd.'s return on equity of 11.96% beat Edesa Biotech, Inc.'s return on equity of -77.48%.
Company Gross Margin Earnings Per Share Invested Capital OILFFNextleaf Solutions Ltd.19.98% -- $4.5M EDSAEdesa Biotech, Inc.-- -$0.32 $12.5M -
What do Analysts Say About OILFF or EDSA?
Nextleaf Solutions Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Edesa Biotech, Inc. has an analysts' consensus of $11.00 which suggests that it could grow by 643.24%. Given that Edesa Biotech, Inc. has higher upside potential than Nextleaf Solutions Ltd., analysts believe Edesa Biotech, Inc. is more attractive than Nextleaf Solutions Ltd..
Company Buy Ratings Hold Ratings Sell Ratings OILFFNextleaf Solutions Ltd.0 0 0 EDSAEdesa Biotech, Inc.2 0 0 -
Is OILFF or EDSA More Risky?
Nextleaf Solutions Ltd. has a beta of 1.769, which suggesting that the stock is 76.904% more volatile than S&P 500. In comparison Edesa Biotech, Inc. has a beta of 0.078, suggesting its less volatile than the S&P 500 by 92.204%.
-
Which is a Better Dividend Stock OILFF or EDSA?
Nextleaf Solutions Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Edesa Biotech, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nextleaf Solutions Ltd. pays -- of its earnings as a dividend. Edesa Biotech, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OILFF or EDSA?
Nextleaf Solutions Ltd. quarterly revenues are $2.1M, which are larger than Edesa Biotech, Inc. quarterly revenues of --. Nextleaf Solutions Ltd.'s net income of -$8.6K is higher than Edesa Biotech, Inc.'s net income of -$2.2M. Notably, Nextleaf Solutions Ltd.'s price-to-earnings ratio is 15.35x while Edesa Biotech, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nextleaf Solutions Ltd. is 0.76x versus 31.22x for Edesa Biotech, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OILFFNextleaf Solutions Ltd.0.76x 15.35x $2.1M -$8.6K EDSAEdesa Biotech, Inc.31.22x -- -- -$2.2M
-
Which has Higher Returns OILFF or LEXX?
Lexaria Bioscience Corp. has a net margin of -0.41% compared to Nextleaf Solutions Ltd.'s net margin of -2178.51%. Nextleaf Solutions Ltd.'s return on equity of 11.96% beat Lexaria Bioscience Corp.'s return on equity of -147.19%.
Company Gross Margin Earnings Per Share Invested Capital OILFFNextleaf Solutions Ltd.19.98% -- $4.5M LEXXLexaria Bioscience Corp.91.15% -$0.14 $5.3M -
What do Analysts Say About OILFF or LEXX?
Nextleaf Solutions Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Lexaria Bioscience Corp. has an analysts' consensus of $6.00 which suggests that it could grow by 815.44%. Given that Lexaria Bioscience Corp. has higher upside potential than Nextleaf Solutions Ltd., analysts believe Lexaria Bioscience Corp. is more attractive than Nextleaf Solutions Ltd..
Company Buy Ratings Hold Ratings Sell Ratings OILFFNextleaf Solutions Ltd.0 0 0 LEXXLexaria Bioscience Corp.0 0 0 -
Is OILFF or LEXX More Risky?
Nextleaf Solutions Ltd. has a beta of 1.769, which suggesting that the stock is 76.904% more volatile than S&P 500. In comparison Lexaria Bioscience Corp. has a beta of 0.628, suggesting its less volatile than the S&P 500 by 37.221%.
-
Which is a Better Dividend Stock OILFF or LEXX?
Nextleaf Solutions Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Lexaria Bioscience Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nextleaf Solutions Ltd. pays -- of its earnings as a dividend. Lexaria Bioscience Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OILFF or LEXX?
Nextleaf Solutions Ltd. quarterly revenues are $2.1M, which are larger than Lexaria Bioscience Corp. quarterly revenues of $174K. Nextleaf Solutions Ltd.'s net income of -$8.6K is higher than Lexaria Bioscience Corp.'s net income of -$2.7M. Notably, Nextleaf Solutions Ltd.'s price-to-earnings ratio is 15.35x while Lexaria Bioscience Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nextleaf Solutions Ltd. is 0.76x versus 14.86x for Lexaria Bioscience Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OILFFNextleaf Solutions Ltd.0.76x 15.35x $2.1M -$8.6K LEXXLexaria Bioscience Corp.14.86x -- $174K -$2.7M
-
Which has Higher Returns OILFF or ONCY?
Oncolytics Biotech, Inc. has a net margin of -0.41% compared to Nextleaf Solutions Ltd.'s net margin of --. Nextleaf Solutions Ltd.'s return on equity of 11.96% beat Oncolytics Biotech, Inc.'s return on equity of -635.07%.
Company Gross Margin Earnings Per Share Invested Capital OILFFNextleaf Solutions Ltd.19.98% -- $4.5M ONCYOncolytics Biotech, Inc.-- -$0.10 $682.8K -
What do Analysts Say About OILFF or ONCY?
Nextleaf Solutions Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Oncolytics Biotech, Inc. has an analysts' consensus of $5.55 which suggests that it could grow by 449.6%. Given that Oncolytics Biotech, Inc. has higher upside potential than Nextleaf Solutions Ltd., analysts believe Oncolytics Biotech, Inc. is more attractive than Nextleaf Solutions Ltd..
Company Buy Ratings Hold Ratings Sell Ratings OILFFNextleaf Solutions Ltd.0 0 0 ONCYOncolytics Biotech, Inc.3 1 0 -
Is OILFF or ONCY More Risky?
Nextleaf Solutions Ltd. has a beta of 1.769, which suggesting that the stock is 76.904% more volatile than S&P 500. In comparison Oncolytics Biotech, Inc. has a beta of 0.880, suggesting its less volatile than the S&P 500 by 11.965%.
-
Which is a Better Dividend Stock OILFF or ONCY?
Nextleaf Solutions Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Oncolytics Biotech, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nextleaf Solutions Ltd. pays -- of its earnings as a dividend. Oncolytics Biotech, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OILFF or ONCY?
Nextleaf Solutions Ltd. quarterly revenues are $2.1M, which are larger than Oncolytics Biotech, Inc. quarterly revenues of --. Nextleaf Solutions Ltd.'s net income of -$8.6K is higher than Oncolytics Biotech, Inc.'s net income of -$10.5M. Notably, Nextleaf Solutions Ltd.'s price-to-earnings ratio is 15.35x while Oncolytics Biotech, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nextleaf Solutions Ltd. is 0.76x versus -- for Oncolytics Biotech, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OILFFNextleaf Solutions Ltd.0.76x 15.35x $2.1M -$8.6K ONCYOncolytics Biotech, Inc.-- -- -- -$10.5M
-
Which has Higher Returns OILFF or XENE?
Xenon Pharmaceuticals, Inc. has a net margin of -0.41% compared to Nextleaf Solutions Ltd.'s net margin of -867.29%. Nextleaf Solutions Ltd.'s return on equity of 11.96% beat Xenon Pharmaceuticals, Inc.'s return on equity of -44.39%.
Company Gross Margin Earnings Per Share Invested Capital OILFFNextleaf Solutions Ltd.19.98% -- $4.5M XENEXenon Pharmaceuticals, Inc.-- -$1.15 $567.8M -
What do Analysts Say About OILFF or XENE?
Nextleaf Solutions Ltd. has a consensus price target of --, signalling downside risk potential of --. On the other hand Xenon Pharmaceuticals, Inc. has an analysts' consensus of $55.40 which suggests that it could grow by 25.63%. Given that Xenon Pharmaceuticals, Inc. has higher upside potential than Nextleaf Solutions Ltd., analysts believe Xenon Pharmaceuticals, Inc. is more attractive than Nextleaf Solutions Ltd..
Company Buy Ratings Hold Ratings Sell Ratings OILFFNextleaf Solutions Ltd.0 0 0 XENEXenon Pharmaceuticals, Inc.17 0 0 -
Is OILFF or XENE More Risky?
Nextleaf Solutions Ltd. has a beta of 1.769, which suggesting that the stock is 76.904% more volatile than S&P 500. In comparison Xenon Pharmaceuticals, Inc. has a beta of 1.027, suggesting its more volatile than the S&P 500 by 2.689%.
-
Which is a Better Dividend Stock OILFF or XENE?
Nextleaf Solutions Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xenon Pharmaceuticals, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Nextleaf Solutions Ltd. pays -- of its earnings as a dividend. Xenon Pharmaceuticals, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios OILFF or XENE?
Nextleaf Solutions Ltd. quarterly revenues are $2.1M, which are larger than Xenon Pharmaceuticals, Inc. quarterly revenues of --. Nextleaf Solutions Ltd.'s net income of -$8.6K is higher than Xenon Pharmaceuticals, Inc.'s net income of -$90.9M. Notably, Nextleaf Solutions Ltd.'s price-to-earnings ratio is 15.35x while Xenon Pharmaceuticals, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Nextleaf Solutions Ltd. is 0.76x versus 463.46x for Xenon Pharmaceuticals, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income OILFFNextleaf Solutions Ltd.0.76x 15.35x $2.1M -$8.6K XENEXenon Pharmaceuticals, Inc.463.46x -- -- -$90.9M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 20
Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.
Buy
54
BMRN alert for Dec 20
BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.
Buy
82
RKLB alert for Dec 20
Rocket Lab Corp. [RKLB] is up 17.72% over the past day.
